Plasma thrombopoietin in patients with cavernous transformation of the portal vein


Goker H., Egesel T., Karakus S., Haznedaroglu I., Apras S., Buyukasik Y., ...Daha Fazla

INTERNATIONAL JOURNAL OF HEMATOLOGY, cilt.75, sa.1, ss.91-94, 2002 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 75 Sayı: 1
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1007/bf02981986
  • Dergi Adı: INTERNATIONAL JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.91-94
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Thrombopoietin (TPO), the primary regulator of thrombopoiesis, is produced mainly in the liver. Previous studies investigating blood TPO in chronic liver diseases revealed conflicting results. It has been suggested that hepatic TPO production is regulated by the portal blood supply to the liver. However, the role of TPO in the pathobiological basis of idiopathic portal vein thrombosis (PVT) and cavernous transformation of the portal vein (CTPV) has not been elucidated. The objective of this study is to assess plasma TPO concentrations in patients with CTPV. Eleven patients (4 men and 7 women, aged 38 12 years) with CTPV were studied. Sixteen healthy adults served as the control group (8 men and 8 women, aged 34 12 years). Median plasma TPO concentration was 326 pg/mL (range, 15-1402 pg/mL) in the patients with CTPV and 62.65 pg/mL (range, 38.5-102 pg/mL) in the control group (P = .003). In this study, we found significantly higher TPO concentrations in the plasma of patients with CTPV. The higher concentrations could be a result of the altered portal hemodynamics due to thrombosis. Moreover, TPO release by activated platelets might lead to the subsequent propagation of thrombosis in PVT. Int J Hematol. 2002;75:91-94. (C)2002 The Japanese Society of Hematology.